CN-STANDARD
Notice: 362066-2026
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V für die Wirkstoffe Bevacizumab und Rituximab
| Contracting Authority | GWQ ServicePlus AG |
| Country | Germany (DEU) |
| CPV Code | 33600000 |
| Publication Date | 27 May 2026 |
| Deadline | Not specified |
| Value | Not specified |
| Currency | EUR |
| Notice Type | cn-standard |
📄 Full notice available on TED Europa (EU Official Journal of the European Union)
View Full Notice on TED →